Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Agios Pharmaceuticals (AGIO) over the last 13 years, with Q3 2025 value amounting to 0.03.

  • Agios Pharmaceuticals' Asset Utilization Ratio rose 2233.19% to 0.03 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03, marking a year-over-year increase of 2233.19%. This contributed to the annual value of 0.03 for FY2024, which is 1385.75% up from last year.
  • As of Q3 2025, Agios Pharmaceuticals' Asset Utilization Ratio stood at 0.03, which was up 2233.19% from 0.03 recorded in Q2 2025.
  • Over the past 5 years, Agios Pharmaceuticals' Asset Utilization Ratio peaked at 0.07 during Q1 2021, and registered a low of 0.0 during Q1 2022.
  • Over the past 5 years, Agios Pharmaceuticals' median Asset Utilization Ratio value was 0.02 (recorded in 2024), while the average stood at 0.02.
  • In the last 5 years, Agios Pharmaceuticals' Asset Utilization Ratio plummeted by 9913.67% in 2022 and then surged by 255253.37% in 2023.
  • Quarter analysis of 5 years shows Agios Pharmaceuticals' Asset Utilization Ratio stood at 0.03 in 2021, then plummeted by 54.34% to 0.01 in 2022, then skyrocketed by 134.35% to 0.03 in 2023, then dropped by 23.42% to 0.02 in 2024, then skyrocketed by 48.41% to 0.03 in 2025.
  • Its Asset Utilization Ratio was 0.03 in Q3 2025, compared to 0.03 in Q2 2025 and 0.02 in Q1 2025.